A case study presented at the annual meeting of the American College of Allergy, Asthma and Immunology shows that it’s possible to develop allergic pulmonary disease, known as “Saxophone Lung,” in response to the mold that collects over time in woodwind instruments. Saxophone Lung is really a type of hypersensitivity pneumonitis, which is the inflammation of the lung tissue, according to the Mayo Clinic.
One of the most problematic aspects of clarinet playing is achieving an even, fluid timbre across the instrument’s range, through all dynamics and articulations. Barring extreme altissimo, the most unforgiving notes on the instrument are the throat tones – F, F#, G, Ab, A, and Bb. They tend to be weak, stuffy, out of tune, hard to project, and unpredictable from player to player.
I ALWAYS play my throat tone Bb with the “resonance fingering.” It’s something I think I started doing in college while using a “crappy” Buffet clarinet they had (by “crappy” I mean it played the throat tones out of tune and stuffy).
Today, MakeMusic announced that Launch Equity will purchase the company. You can read MakeMusic’s press release here. Launch Equity proposed the buyout last July (July 15, 2012), with the intent of taking the company private and then investing money into the company for a new CEO as well as updating software (particularly Finale’s base code).